Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Chronic Infection”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00160251
What this trial is testing

Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 357
Not applicableStudy completedNCT00606528
What this trial is testing

FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy

Who this might be right for
Chronic Hepatitis C Virus Infection
University Health Network, Toronto 54
Not applicableUnknownNCT04211844
What this trial is testing

Metabolic Changes in Chronic HCV Patients Receiving DAAS

Who this might be right for
Chronic Hepatitis C
Ain Shams University 100
Early research (Phase 1)Study completedNCT00905632
What this trial is testing

4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 75
Testing effectiveness (Phase 2)Study completedNCT00546715
What this trial is testing

A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 95
Large-scale testing (Phase 3)WithdrawnNCT01858961
What this trial is testing

Open Label Trial to Compare BI 207127 to Telaprevir in HCV Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim
Testing effectiveness (Phase 2)Study completedNCT01483742
What this trial is testing

Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated Cirrhosis

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 43
Testing effectiveness (Phase 2)Study completedNCT00513461
What this trial is testing

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

Who this might be right for
Adult Primary Liver CancerHepatitis C Infection
Chao Family Comprehensive Cancer Center 110
Not applicableUnknownNCT02511496
What this trial is testing

Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia

Who this might be right for
Chronic Hepatitis CHuman Immunodeficiency Virus (HIV)
Maimónides Biomedical Research Institute of Córdoba 2,800
Testing effectiveness (Phase 2)Ended earlyNCT00874796
What this trial is testing

Efficacy and Safety Study of GS-9450 Treatment for 6 Months in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
HCV Infection
Gilead Sciences 307
Testing effectiveness (Phase 2)Study completedNCT00983060
What this trial is testing

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Who this might be right for
Chronic Hepatitis C Genotype-1 Relapse
Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Study completedNCT02745535
What this trial is testing

Safety, Tolerability and Efficacy of Sofosbuvir, Velpatasvir, and Voxilaprevir in Subjects With Previous DAA Experience

Who this might be right for
Chronic Hepatitis C
University of Maryland, Baltimore 77
Testing effectiveness (Phase 2)Study completedNCT00395421
What this trial is testing

Study to Evaluate Drug-drug Interaction Between Valopicitabine and Ribavirin

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC 114
Large-scale testing (Phase 3)Study completedNCT00800735
What this trial is testing

PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 30
Testing effectiveness (Phase 2)Study completedNCT00292084
What this trial is testing

An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Large-scale testing (Phase 3)Study completedNCT02707952
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 295
Large-scale testing (Phase 3)Study completedNCT00596843
What this trial is testing

Chronic Hepatitis Intervention Project for Drug Users

Who this might be right for
HIVHepatitis C
National Institute on Drug Abuse (NIDA) 851
Testing effectiveness (Phase 2)Study completedNCT01332955
What this trial is testing

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen

Who this might be right for
Hepatitis C, ChronicHIV Infection
ANRS, Emerging Infectious Diseases 70
Testing effectiveness (Phase 2)Study completedNCT00088140
What this trial is testing

A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients

Who this might be right for
Hepatitis C, Chronic
Conatus Pharmaceuticals Inc. 204
Testing effectiveness (Phase 2)Study completedNCT02253550
What this trial is testing

Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C
Peter J. Ruane, M.D. 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation